首页 >
法规速递
-
Document: Decision of the Executive Director on rules governing the traineeship programme at the EMA-2026/7/13
2026-07-14查看详情 > -
国家药监局关于修订昂丹司琼制剂说明书的公告（2023年第12号）-2023/01/16
2023-01-16查看详情 > -
国家药监局关于修订三七伤药制剂、消炎止咳制剂药品说明书的公告（2023年第104号）-2023/8/21
2023-08-24查看详情 > -
国家药监局药审中心关于在中国上市药品专利信息登记平台设置法律文书提交模块的通知-2024/2/26
2024-03-12查看详情 > -
Institutional Review Boards Frequently Asked Questions Guidance for Institutional Review Boards and Clinical Investigators-2025/2/5
2025-02-06查看详情 > -
Document: Superseded Community herbal monograph on Urtica dioica L., Urtica urens L., their hybrids or their mixtures, radix - First version-2025/3/12
2025-03-13查看详情 > -
Document: Key information section in package leaflet of centrally authorised medicinal products: Public consultation-2025/4/14
2025-04-15查看详情 > -
Document: Overview of (invented) names reviewed in April 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 22 May 2025-2025/5/27
2025-05-28查看详情 > -
Page: Paracetamol product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Page: Recommendations on medication errors-2025/8/1
2025-08-04查看详情 >
